Biolidics Ltd is a medical technology company focused on the development of cell enrichment systems. Its developed and commercialised product is ClearCell FX1 System, a fully automated in vitro diagnostic medical device, which relies on a novel, patented technology to separate and enrich cancer cells from blood. It operates in the business segments of Technical and product development; Global commercial channel management and Corporate segment. The global commercial channel management segment, which is the key revenue generating segment, involves the management of global distributorship network and direct customers. The group has a business presence in Singapore and other countries.